Zanzalintinib |
XL-092 |
Phase 3 Clinical |
Exelixis Inc |
Solid tumours; Leiomyosarcoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Carcinoma, Transitional Cell; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Colorectal Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular |
Details
|
KC1036 |
KC1036; KC-1036 |
Phase 3 Clinical |
Beijing Konruns Pharmaceutical Co Ltd |
Hematologic Neoplasms; Solid tumours; Digestive System Neoplasms; Sarcoma, Ewing; Thymus Neoplasms; Esophageal Squamous Cell Carcinoma; Adenocarcinoma; Neoplasm Metastasis |
Details
|
Sitravatinib |
MGCD-516; IND-155305; MGCD-0516; MG-91516; MG-516 |
Phase 3 Clinical |
Mirati Therapeutics Inc |
Breast Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Endometrial Neoplasms; Lung Neoplasms; Metastatic breast cancer; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Carcinoma, Squamous Cell; Hepatic Insufficiency; Ureteral Neoplasms; Solid tumours; Lung Diseases; Liposarcoma; Uveal melanoma; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Carcinoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Kidney Neoplasms; Biliary Tract Neoplasms |
Details
|
Ningetinib Tosylate |
CT-053-PTSA; CT-053 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Solid tumours; Intestinal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Mecbotamab vedotin |
BA-3011; BA3011; BA 3011 |
Phase 2 Clinical |
Bioatla |
Ovarian Neoplasms; Dermatofibrosarcoma; Sarcoma; Carcinoma, Non-Small-Cell Lung |
Details
|
Merestinib |
5OGS5K699E; LY-2801653 |
Phase 2 Clinical |
Eli Lilly And Company |
Biliary Tract Neoplasms; Solid tumours; Skin Melanoma; Bone metastases; Pancreatic Neoplasms; Neoplasms; Microsatellite instability-high cancer; Breast Neoplasms; Cholangiocarcinoma; Lymphoma, Mantle-Cell; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
Tamnorzatinib |
ONO-7475 |
Phase 2 Clinical |
Ono Pharmaceutical Co Ltd |
Leukemia; Solid tumours; Myelodysplastic Syndromes; Pancreatic Neoplasms; Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung |
Details
|
Bemcentinib |
BGB-324; R-428; BGB-3234 |
Phase 2 Clinical |
Rigel Pharmaceuticals Inc |
Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Adenocarcinoma of Lung; Myelodysplastic Syndromes; Inflammatory Breast Neoplasms; Triple Negative Breast Neoplasms; Glioblastoma; Central Nervous System Neoplasms; Mesothelioma; Brain Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
Enapotamab vedotin |
AXL-107-MMAE |
Phase 2 Clinical |
Seagen Inc, Genmab A/S |
Solid tumours; Ovarian Neoplasms; Sarcoma; Endometrial Neoplasms; Thyroid Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
FC-084-CSA |
FC084CSA; FC-084-CSA |
Phase 2 Clinical |
FindCure Biosciences (ZhongShan) Co Ltd |
Solid tumours |
Details
|
XZB-0004 |
XZB-0004; SLC-0211; SLC-391 |
Phase 2 Clinical |
Xuanzhu (Shijiazhuang) Biotechnology Co Ltd |
Solid tumours; Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Foodborne Diseases |
Details
|
Butylidenephthalide |
NSC-325307; LF-001 (Everfront Biotech); EF-001; HK-001; BDPH |
Phase 2 Clinical |
Everfront Biotech Co Ltd |
Glioblastoma; Glioma; Amyotrophic Lateral Sclerosis |
Details
|
Adrixetinib |
Q-702 |
Phase 2 Clinical |
Vichem Chemie, Max Planck Institute of Biochemistry, Lead Discovery Center GmbH |
Lymphoma, Follicular; Central Nervous System Lymphoma; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Neoplasm Metastasis; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Waldenstrom Macroglobulinemia; Primary Myelofibrosis; Histiocytic Sarcoma; Erdheim-Chester Disease; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Histiocytosis, Sinus; Neoplasms; Graft vs Host Disease; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Stomach Neoplasms; Esophageal Neoplasms; Leukemia, Lymphoid; Solid tumours; Lymphoma, T-Cell, Peripheral |
Details
|
Dubermatinib |
TP-0903 |
Phase 1 Clinical |
Sumitomo Dainippon |
Solid tumours; Ovarian Neoplasms; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
INCB-081776 |
INCB-81776; INCB-081776 |
Phase 1 Clinical |
Incyte Corp |
Solid tumours; Squamous Cell Carcinoma of Head and Neck |
Details
|
BPI-9016 |
BPI-9016; BPI-9016M |
Phase 1 Clinical |
Betta Pharmaceuticals Co Ltd |
Solid tumours; Carcinoma, Non-Small-Cell Lung |
Details
|
Mipasetamab uzoptirine |
ADCT-601; BGB-601; 1H12-GaINAcN3; 1H12-HAKB |
Phase 1 Clinical |
Adc Therapeutics Sa |
Solid tumours |
Details
|
NP-01 (SSY Group) |
|
Phase 1 Clinical |
|
Solid tumours; Liver Neoplasms; Stomach Neoplasms; Prostatic Neoplasms; Lung Neoplasms |
Details
|
A-416 |
A416; A-416 |
Phase 1 Clinical |
Klus Pharma Inc |
Solid tumours |
Details
|
NTQ-2494 |
NTQ2494; NTQ-2494 |
Phase 1 Clinical |
Nanjing Zhengda Tianqing Pharmaceutical Co Ltd |
Solid tumours; Hematologic Neoplasms; Leukemia, Myeloid, Acute |
Details
|
CTS-2016 |
CTS-2016 |
Phase 1 Clinical |
CytosinLab Therapeutics Co Ltd |
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute |
Details
|
AB-801 |
AB-801 |
Phase 1 Clinical |
Arcus Biosciences Inc |
Neoplasms |
Details
|
NP-107 |
NP107; NP-107 |
Phase 1 Clinical |
Shanghai Nawei Biotechnology Co Ltd |
Solid tumours |
Details
|
TT-00973 |
TT-00973 |
Phase 1 Clinical |
TransThera Sciences (Nanjing) Inc |
Solid tumours |
Details
|
AGX-0073 |
AGX-0073 |
Phase 1 Clinical |
Shanghai Aojian Biological Technology Co Ltd |
Solid tumours |
Details
|
PF-07265807 |
PF-07265807 |
Phase 1 Clinical |
Pfizer Inc |
Solid tumours; Neoplasm Metastasis |
Details
|
Denfivontinib Hydrochloride |
SKI-G-801; G-801; G-749 Hydrochloride |
Phase 1 Clinical |
Genosco |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
NP-01 (Shijiazhuang No.4 Pharmaceutical/Nanjing Nadingfei Medical Technology) |
NP-01 |
Phase 1 Clinical |
Shijiazhuang No 4 Pharmaceutical Co Ltd, Nanjing Nadingfei Pharmaceutical Technology Co Ltd |
Liver Neoplasms; Solid tumours; Stomach Neoplasms; Lung Neoplasms |
Details
|
NPS-1034 |
HOPE-777; KDDF-201111-02 |
|
Neopharma Ltd |
|
Details
|
cancer therapeutics (BerGenBio) |
BGB-101; BGB-109; BGB-003; BGB-001 |
|
Bergenbio |
|
Details
|